Search Results - "van Beek, Jasper J P"

  • Showing 1 - 15 results of 15
Refine Results
  1. 1

    A fresh look at the T helper subset dogma by van Beek, Jasper J. P., Rescigno, Maria, Lugli, Enrico

    Published in Nature immunology (01-02-2021)
    “…Single-cell-sequencing techniques enable the decades-old T helper subset dogma to be re-examined in an unsupervised manner, bringing nuance to the definition…”
    Get full text
    Journal Article
  2. 2
  3. 3

    Insight into Mucinous Colorectal Carcinoma: Clues from Etiology by Hugen, Niek, van Beek, Jasper J. P., de Wilt, Johannes H. W., Nagtegaal, Iris D.

    Published in Annals of surgical oncology (01-09-2014)
    “…The prognostic impact of mucinous carcinoma (MC) in colorectal cancer (CRC) has been subject to debate ever since the introduction of the classification of…”
    Get full text
    Journal Article
  4. 4
  5. 5
  6. 6

    Protamine-stabilized RNA as an ex vivo stimulant of primary human dendritic cell subsets by Sköld, Annette E., van Beek, Jasper J. P., Sittig, Simone P., Bakdash, Ghaith, Tel, Jurjen, Schreibelt, Gerty, de Vries, I. Jolanda M.

    Published in Cancer Immunology, Immunotherapy (01-11-2015)
    “…Dendritic cells (DCs) are key in connecting innate and adaptive immunity. Their potential in inducing specific immune responses has made them interesting…”
    Get full text
    Journal Article
  7. 7

    Human blood myeloid and plasmacytoid dendritic cells cross activate each other and synergize in inducing NK cell cytotoxicity by van Beek, Jasper J. P., Gorris, Mark A. J., Sköld, Annette E., Hatipoglu, Ibrahim, Van Acker, Heleen H., Smits, Evelien L., de Vries, I. Jolanda M., Bakdash, Ghaith

    Published in Oncoimmunology (01-01-2016)
    “…Human blood dendritic cells (DCs) hold great potential for use in anticancer immunotherapies. CD1c + myeloid DCs and plasmacytoid DCs (pDCs) have been…”
    Get full text
    Journal Article
  8. 8
  9. 9
  10. 10

    Human pDCs Are Superior to cDC2s in Attracting Cytolytic Lymphocytes in Melanoma Patients Receiving DC Vaccination by van Beek, Jasper J.P., Flórez-Grau, Georgina, Gorris, Mark A.J., Mathan, Till S.M., Schreibelt, Gerty, Bol, Kalijn F., Textor, Johannes, de Vries, I. Jolanda M.

    Published in Cell reports (Cambridge) (28-01-2020)
    “…Plasmacytoid dendritic cells (pDCs) and type 2 conventional dendritic cells (cDC2s) are currently under evaluation for use in cancer vaccines. Although both DC…”
    Get full text
    Journal Article
  11. 11
  12. 12
  13. 13

    Dendritic cell cross talk with innate and innate-like effector cells in antitumor immunity: implications for DC vaccination by van Beek, Jasper J P, Wimmers, Florian, Hato, Stanleyson V, de Vries, I Jolanda M, Sköld, Annette E

    Published in Critical reviews in immunology (2014)
    “…Dendritic cells (DCs) are key players in the induction of immune responses. Adoptive transfer of autologous mature DCs loaded with tumor-associated antigens is…”
    Get full text
    Journal Article
  14. 14

    Innate Lymphoid Cells in Tumor Immunity by van Beek, Jasper J P, Martens, Anne W J, Bakdash, Ghaith, de Vries, I Jolanda M

    Published in Biomedicines (25-02-2016)
    “…Innate lymphoid cells (ILCs) are a group of immune cells of the lymphoid lineage that do not possess antigen specificity. The group includes natural killer…”
    Get full text
    Journal Article
  15. 15